Replies to post #720888 on NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

All BS. You don't let your share price bleed and continue to dilute shareholders to eternity. That is why no institutional investors would back this crew given their history. Instead, a well rounded CEO would have raised a ton of money at $2 or $2.5 or when it was trading around $1.5. She has had to sell 5x more shares now at these prices.

She has time and again showed that she doesnt care for shareholders.

[RobotDroid]

I don’t think I’m being overly generous here. It makes no sense to say they’re bad at running a company while being good at commercializing immunotherapy at scale. I’ll forgive the obfuscation, delays, and even dishonesty if it’s all in service of a bigger narrative that we just can’t fully see yet.
This is hilarious. You just described an inept nonmanagment team and listed their faults that HAVE occured. They really really suck at this whole process, and are one of the worst, if not the worst, nonmanagement teams ever.

[Rh2022]

Very much agreed. Well-said.

[learningcurve2020]

How's that all work exactly?

>>It unnerved her because a major investor might have created another Woodford-shaped problem for her.


Translation -They're good at building private CDMO's while letting their shareholders languish.

>>I don’t think I’m being overly generous here. It makes no sense to say they’re bad at running a company while being good at commercializing immunotherapy at scale.


Translation - Material events reporting out the window!

>>I’ll forgive the obfuscation, delays, and even dishonesty if it’s all in service of a bigger narrative that we just can’t fully see yet.

PS- waiting on the combo wasn't Flipper's narrative. I said it too just that I expected they'd need to come clean and tell investors.

But even if the combo shows real efficacy there's still the cost issue hurdle.